N
RXII

Nuveen’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Nuveen’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,136
Closed -$4K – 1633
2016
Q3 		$4K Hold
12,136
– – ﹤0.01% 1396
2016
Q2 		$6K Buy
12,136
+564
+5% +$279 ﹤0.01% 1306
2016
Q1 		$16 Hold
11,572
– – ﹤0.01% 1382
2015
Q4 		$17 Hold
11,572
– – ﹤0.01% 1497
2015
Q3 		$18 Hold
11,572
– – ﹤0.01% 1532
2015
Q2 		$20 Hold
11,572
– – ﹤0.01% 1581
2015
Q1 		$16K Buy
+11,572
New +$16K ﹤0.01% 1581

Nuveen's RXII Position: Q4 2016 in Review

Nuveen sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 12,136 shares — an estimated $4K sold.

Nuveen first reported a position in RXII in Q1 2015 and held it in 7 quarters. The position peaked at $16K in Q1 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Nuveen reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Nuveen sold 12,136 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
  • Nuveen first reported a position in GALENA BIOPHARMA INC COM in Q1 2015 and held it in 7 quarters.
  • Nuveen's GALENA BIOPHARMA INC COM position peaked at $16K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Nuveen's 13F filing for Q4 2016, filed 14 Feb 2017.